Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation

This publication has 23 references indexed in Scilit:

• Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen–presenting cells
  Blood, 2002
• Comparison of short tandem repeat and variable number tandem repeat genetic markers for quantitative determination of allogeneic bone marrow transplant engraftment
  Bone Marrow Transplantation, 2002
• The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse
  Transplantation and Cellular Therapy, 2001
• Donor lymphocyte infusions
  Current Opinion in Hematology, 1999
• In Relapsed Patients after Lymphocyte Depleted Bone Marrow Transplantation the Percentage of Donor T Lymphocytes Correlates Well with the Outcome of Donor Leukocyte Infusion
  Leukemia & Lymphoma, 1999
• Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells
  Bone Marrow Transplantation, 1998
• Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A REPORT BY THE EBMT LEUKAEMIA WORKING PARTY
  British Journal of Haematology, 1991
• Chronic graft-versus-host syndrome in man
  The American Journal of Medicine, 1980
• Bone-Marrow Transplantation
  New England Journal of Medicine, 1975
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958